LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $8,573,000 | -4.1% | 99,562 | -0.7% | 3.85% | -7.4% |
| Q2 2022 | $8,944,000 | +7.9% | 100,244 | +36.0% | 4.16% | +21.0% |
| Q1 2022 | $8,291,000 | -74.4% | 73,700 | -77.4% | 3.44% | -86.1% |
| Q4 2020 | $32,431,000 | +5.8% | 326,100 | +1.4% | 24.83% | -22.1% |
| Q3 2020 | $30,645,000 | +196.5% | 321,500 | +247.9% | 31.88% | +59.2% |
| Q2 2020 | $10,336,000 | -11.7% | 92,407 | -42.6% | 20.02% | +61.8% |
| Q1 2020 | $11,702,000 | +292.3% | 160,919 | +437.0% | 12.38% | +327.5% |
| Q3 2019 | $2,983,000 | -84.4% | 29,965 | -82.1% | 2.90% | -78.0% |
| Q2 2019 | $19,119,000 | +1.4% | 167,487 | +11.7% | 13.16% | +21.4% |
| Q1 2019 | $18,857,000 | – | 150,000 | – | 10.85% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |